Navigation Links
Doctors must collaborate so that patients get full benefit of tamoxifen treatment
Date:3/24/2010

s. "Our study differs in that we have been able to take action as soon as we have discovered that a patient is taking interacting medication(s) by contacting the prescribing doctor in order to get them to switch to a different medication with no deleterious effect on tamoxifen metabolism."

In many cases, Mr. Hopkins was able to identify those patients using interacting SSRIs before starting tamoxifen treatment, either to give them time to be weaned off onto another class of drug or to start them on a different cancer therapy such as an aromatase inhibitor (AI). CYP2D6 inhibitors do not have the same effect on AIs, but one in five patients discontinue taking AIs because of side effects2; if they change to tamoxifen while continuing to take enzyme inhibitors, there may be a longer overlap of therapies, says Mr. Hopkins.

"For these patients, having the knowledge to be able to plan effectively in advance is important, as it can take many weeks to wean patients off CYP2D6 inhibitors, and this may affect their breast cancer therapy. The findings mean that good communication between all healthcare providers is more important than ever in order to eliminate the risk of reducing the efficacy of prescribed therapy," he will say.

Using drug data from his hospital's Breast Cancer Disease Site Group clinical database, the researchers logged any patient on tamoxifen or AI therapy as well as those on CYP2D6 inhibitors. A total of 531 patients were found to be eligible for the study; 463 received one of the prescribed hormonal therapies, while 68 were on a CYP2D6 inhibitor but not receiving hormonal treatment. Seven patients receiving tamoxifen and 16 taking an AI were also on a strong CYP2D6 inhibitor five percent of all the patients studied. One patient on tamoxifen and six on an AI were also receiving a moderate enzyme inhibitor, and 24 on tamoxifen and 40 on an AI were taking weak CYP2D6 inhibitors.

Tamoxifen must be metabolised in the li
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. National Hispanic Medical Association Urges U.S. to Improve Health Care Access as Doctors Meet March 25-28 in Washington
2. Ranking Doctors by Cost-Profile May Not Help Save Money
3. Court Hearing Thursday on Physicians Challenge to Obamacare: Doctors Argue Against Arbitrary Power and Tyranny
4. Doctors Support Efforts of Employers and Health Plans to Improve Health of Patients
5. Over 500 Doctors Descend Into Abu Dhabi to Attend the 1st International Abu Dhabi Diabetes Congress
6. The Elizabeth Birt Center for Autism Law and Advocacy (EBCALA) Objects to Media Reports Tainting Autism Doctors and Misrepresenting Autism Treatments
7. Doctors Turning to Cardiac Catheterization Too Quickly
8. Phoenix Magazine Sets Magazine Advertising Sales Record With Best Doctors Issue
9. Sibu Beauty Unveils Three New Products From Sea Buckthorn Berries – as Seen on The Doctors and The Dr. Oz Show
10. People Still Trust Their Doctors Rather Than the Internet
11. Consumer Alert: Denture Cream Maker Warns Doctors of Product Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... PA (PRWEB) July 29, 2014 ... the Sewickley and Moon Township areas, has affiliated with ... Women’s Health will continue to deliver babies and perform ... need of advanced care will be referred to Allegheny ... are proud to be associated with West Penn Hospital ...
(Date:7/29/2014)... 2014 Representatives with BNatrl announced today ... BNatrl Silver Solution 12ppm . , “It’s safe ... for BNatrl LLC. “It helps boost your immune system ... pathogens and microbes.” , BNatrl develops and manufactures organic ... with 10 percent of profits being used to fund ...
(Date:7/29/2014)... 2014 Regents Health Resources, a consulting ... brought health care industry veteran Daryl Demonbreun and former ... lead the company’s ambitious plans to grow into a ... been moving along at a steady pace for nearly ... a notch,” says Bob Maier, founder and chief executive ...
(Date:7/29/2014)... According to the new market research report, "Fingerprint ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile ... & Finance), and Geography - Global Trends & ... the global Fingerprint Sensors Market is projected to ... high CAGR of 16.8% from 2014 to 2020. ...
(Date:7/29/2014)... 2014 This Latest Guidebook for Conducting ... (2014 Edition) not only provided a comprehensive and thorough ... for imported drug registration but also introduced the practical ... guide you to use the Chinese trial venues to ... world step by step. , The audiences of this ...
Breaking Medicine News(10 mins):Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 3Health News:BNatrl Launches New Silver Solution Product 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4
... Va. Research reported in the October issue of ... a molecular imaging technique may prove useful in early ... "One of the most promising aspects of molecular ... long before changes in the tumor size and shape ...
... review article published in the October issue of ... Clinic physicians differentiate the ethical and legal permissibility ... comfort measures, specifically palliative sedation, from that of ... that palliative sedation has an important place on ...
... published study in the October 2010 issue of The ... conducted at New York University,s College of Dentistry, confirms ... for controlling xerostomia, or dry mouth. The double masked, ... unique mucoadhesive patch, affixed to the hard palate inside ...
... It Real," an evidence-based sex education curriculum developed by researchers ... (UTHealth), will be implemented in select public schools across the ... tackle the U.S. teenage pregnancy rate. The U.S. ... of its $155-million total package to a team led by ...
... sciences for the developing world, will hold its 21st General ... 350 scientists from 35 countries are expected to attend. Dr. ... delegates at the opening ceremony. The opening ceremony will ... Ernesto Illy Trieste Science Prize and the official presentation of ...
... is a major cause of vision problems in children and ... 70 in developed countries. In amblyopia the person,s stronger eye ... as a result. When the condition is detected and treated ... 20/30 vision or better, the Amblyopia Treatment Study reports. But ...
Cached Medicine News:Health News:Evaluation of targeted therapy in ovarian cancer 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 3Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:TWAS to meet in India 2Health News:Is photoscreening the best way to catch 'lazy eye'? 2
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
(Date:7/29/2014)...  The Healthcare Analytics Summit 2014 (HAS ... Salt Lake City , Sept. 24-25 has added ... organizations in the U.S. and beyond.  HAS ,14, powered ... devoted to providing immersive learning experiences on the ... accountable care initiatives and population health managemen t ...
(Date:7/29/2014)... July 29, 2014  Ambit Biosciences (Nasdaq: AMBI ... of drugs targeting unmet needs in oncology, autoimmune and ... operational results after closing of the NASDAQ Global Market ... conference call hosted by Michael Martino , president ... take place on the same day at 5:00 pm ...
Breaking Medicine Technology:Global Respiratory Devices Market 2014-2018 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2
... NEW YORK , July 1 ... ("NeoStem" or the "Company"), an international,biopharmaceutical company with operations ... it has appointed Roberto Bolli , M.D., to ... body of stem-cell research,including work emphasizing the ability of ...
... July 1 Sagent Pharmaceuticals, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the ... is a vital anticoagulant, preventing the formation of clots ... used in surgical and dialysis settings.  According to IMS, ...
Cached Medicine Technology:NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 2NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 3NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 4FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Medicine Products: